Financial Position - Total liabilities amounted to CNY 3,426,069,464.07, a decrease of 1.87% from CNY 3,491,547,583.66 in the previous period[12] - The total owner's equity reached CNY 12,123,240,676.43, reflecting an increase from CNY 12,082,392,718.69, indicating a growth of 0.34%[12] - The company’s total current liabilities were CNY 2,638,900,241.66, a slight decrease from CNY 2,687,311,888.90[12] - The total non-current liabilities were CNY 787,169,222.41, down from CNY 804,235,694.76, indicating a decrease of 2.93%[12] - Total assets decreased slightly to ¥15,549,310,140.50 from ¥15,573,940,302.35, a decline of 0.2%[31] - The total number of common shareholders at the end of the reporting period was 99,176, with the largest shareholder holding 23.19% of shares[24] - The equity attributable to shareholders increased to CNY 11,975,609,054.86, reflecting a 0.34% increase from CNY 11,934,849,259.03 at the end of the previous year[61] Cash Flow - Cash and cash equivalents at the end of the period were CNY 4,272,234,730.72, compared to CNY 5,397,069,053.89 at the end of the previous period, showing a decrease of 20.92%[16] - The net cash flow from investing activities was CNY -25,414,677.86, an improvement from CNY -34,578,450.47 in the previous period[16] - The company recorded a net increase in cash and cash equivalents of CNY 22,704,756.21 during the period[16] - The net cash flow from operating activities for Q1 2024 was CNY 85,836,209.42, down 27.89% from CNY 119,028,501.26 in Q1 2023[61] Revenue and Profitability - Total operating revenue for the current period reached ¥1,058,020,658.26, an increase of 13.3% compared to ¥933,960,245.68 in the previous period[30] - Net profit for the current period was ¥73,003,197.91, compared to ¥61,144,259.99 in the previous period, representing a growth of 19.4%[31] - The company reported a basic earnings per share of ¥0.06, an increase from ¥0.05 in the previous period[32] - The net profit attributable to shareholders for Q1 2024 was CNY 72,915,036.00, up 25.05% from CNY 58,309,822.09 in Q1 2023[61] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 72,550,430.52, a significant increase of 91.06% from CNY 37,973,187.44 in the previous year[61] Expenses - Tax and additional fees increased by 150.15% year-on-year to ¥6,382,784.61, primarily due to increased property tax assessments and enhanced market expansion efforts[22] - Sales expenses rose by 42.99% year-on-year to ¥19,275,578.68, reflecting corresponding increases in sales activities[22] - Management expenses increased by 51.64% year-on-year to ¥71,673,148.65, mainly due to higher employee compensation provisions[22] - Financial expenses decreased by 42.87% year-on-year to -¥31,012,643.79, with no related matters this year[22] - Other income, including investment income, rose by 33.90% year-on-year to ¥14,717,159.10, mainly due to increased VAT deductions in advanced manufacturing[22] - Credit impairment losses increased by 1422.93% year-on-year to ¥3,458,541.61, primarily due to a decrease in provisions for bad debts[22] - Income tax expenses surged by 160.38% year-on-year to ¥7,875,361.70, attributed to an increase in taxable income[22] - Minority interests decreased by 96.89% year-on-year to ¥88,161.91, mainly due to a decline in the operating performance of non-wholly-owned subsidiaries[22] Assets and Inventory - Accounts receivable decreased to ¥1,156,870,696.52 from ¥1,242,678,943.94, a reduction of 6.9%[31] - Inventory increased to ¥731,660,998.34 from ¥695,852,924.63, an increase of 5.2%[31] - Research and development expenses rose to ¥47,953,516.62 from ¥43,381,284.67, an increase of 10.5%[31] - Investment properties increased by 94.68% to CNY 3,204,006.77 due to the addition of rental assets during the reporting period[47] - Short-term borrowings decreased significantly by 97.06% to CNY 1,000,733.33 as a result of loan repayments during the reporting period[47] - Other current liabilities increased by 38.31% to CNY 283,074,139.47, primarily due to the increase in confirmed but not yet due notes receivable[47]
风华高科(000636) - 2024 Q1 - 季度财报